Rule 3.19A.2 Appendix 3Y Change of Director's Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public. Introduced 30/09/01 Amended 01/01/11 We (the entity)...
Change of Director's Interest Notice - Marks
Filed with ASX · · 3 pages · English
Release
Alterity Therapeutics Ltd. on 6ix
Earlier from Alterity Therapeutics
- Application for quotation of securities - ATH
- Alterity Therapeutics Filed Form 20-F and XBRL Data with SEC
- $4.2M Options Underwriting Agreement Executed
- Appendix 4E and 2026 Annual Report
- Corporate Governance Statement
Later from Alterity Therapeutics
- Change of Director's Interest Notice - Stamler
- Alterity to Present at Cantor Global Healthcare Conference
- Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
- Cleansing Notice Under Section 708A
- Alterity Therapeutics to Present at ASX SMIDcaps Conference
